Human vascular progenitor cells (green), made from Zambidis’ lab-grown naive stem cells, engraft into blood vessels (red) in a mouse retina. Credit: Elias Zambidis, Johns Hopkins Medicine
Johns Hopkins Medicine scientists say they have successfully turned back the biological hands of time, coaxing adult human cells in the laboratory to revert to a primitive state, and unlocking their potential to replace and repair damage to blood vessels in the retina caused by diabetes.
The findings from this experimental study, they say, advance regenerative medicine techniques aimed at reversing the course of diabetic retinopathy and other blinding eye diseases.
“Our study results bring us a step closer to using stem cells more widely in regenerative medicine, without the historical problems our field has encountered in getting such cells to differentiate and avoid becoming cancerous,” says Elias Zambidis, M.D., Ph.D., associate professor of oncology at the Johns Hopkins Kimmel Cancer Center and a member of Johns Hopkins’ Institute for Cell Engineering.
Results of experiments using human cells and mice were published online March 5 in Nature Communications.
According to the National Eye Institute, diabetic retinopathy is a leading cause of blindness in U.S. adults. By 2050, researchers estimate that some 14.6 million Americans will have the condition, which results in abnormal blood vessel growth in the retina, where light is processed into vision.
For the study, the scientists began their experiments with a fibroblast — a connective tissue cell — taken from a person with type 1 diabetes. Reprogrammed fibroblasts function as “stem” cells, with the potential to give rise to all tissues in the body, including blood vessels.
The Johns Hopkins team, including research associate Tea Soon Park, Ph.D., reprogrammed the fibroblast stem cells to revert to a state that is even more primitive than that of conventional human induced pluripotent stem cells — more like the state of embryonic cells about six days after fertilization. This is when cells are the most “naive,” or more capable of developing into any specialized type of cell with a much higher efficiency than conventional human induced pluripotent stem cells.
To do this, the scientists bathe the cells in a cocktail of nutrients and chemicals. What should go into the cocktail to build a better naive stem cell has been a subject of debate over the past decade.
Zambidis’ team used a cocktail mixture of two drugs that other scientists previously used to reprogram stem cells: GSK3? inhibitor CHIR99021, which blocks carbohydrate storage in cells, and MEK inhibitor PD0325901, an experimental anti-cancer drug that can block cancer cell growth. The team had also looked at the potential of a third drug, a PARP inhibitor — a popular anticancer drug used to treat a variety of cancers including those of the ovaries and breast.
To the researchers’ surprise, Zambidis says, the trifecta of MEK, GSK3? and PARP inhibitors worked to wind back the cells’ biological clock. He calls the cocktail 3i, named for the three inhibitors. Zambidis’ team had first reported experiments using the three-drug cocktail in 2016.
For the new study, the research team tracked the reprogrammed stem cells’ molecular profile, including measures of proteins such as NANOG, NR5A2, DPPA3 and E-cadherin that guide cell differentiation. That profile appeared similar to that found in so-called naive epiblast cells, the primitive cells that make up an approximately six day-old human embryo.
The scientists also found that the stem cells reprogrammed with the 3i cocktail did not have abnormal changes in factors that can alter core DNA, called epigenetics, that typically plague other lab-made versions of naive stem cells.
Finally, the research team injected cells called vascular progenitors, which were made from the naive stem cells and are capable of making new blood vessels, into the eyes of mice bred to have a form of diabetic retinopathy that results from blood vessels closing off in the retina. They found that the naive vascular progenitors migrated into the retina’s innermost tissue layer that encircles the eye, with higher efficiencies than have been reported with vascular cells made from conventional stem cell approaches. The naive vascular cells took root there, and most survived in the retina for the duration of the four-week study.
“Interestingly, the 3i ‘naive reprogramming’ cocktail appeared to erase disease-associated epigenetics in the donor cells, and brought them back to a healthy, pristine non-diabetic stem cell state,” says Zambidis.
For comparison, the team reprogrammed diabetic fibroblasts to non-naive stem cells using standard methods, and the resulting vascular progenitor cells failed to migrate as deeply into the retina or survive the length of the study.
Zambidis, Park and the other research team members say more experiments are needed to refine the 3i cocktail and to study the regenerative capacity of the stem cells they grow from the cocktail.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Regenerative medicine techniques
- Everyone Should Build At Least One Regenerative Radio Receiver
The answer lies in an extremely clever circuit: the regenerative detector. A small amount of positive feedback is applied to an amplifier that has a tuned circuit in its path, and the effect is ...
- Simple One-Chip Regenerative Receiver
Crystal radios may be the simplest kind to make, but regenerative receivers are more practical and only a little more complicated. A recent design by [Selenium] is super simple because it uses a ...
- The surprising biomedical legacy of the Iraq War
Monday marked the 20th anniversary of the Iraq war, which resulted in an estimated 110,600 deaths of Iraqis and 4,431 U.S. servicemembers killed and ...
- Regenerative medicine alternative to surgery | Healthwatch 16
He consulted with Dr. Justin Tunis at Geisinger Orthopaedics & Sports Medicine, and they decided to try a type of regenerative medicine called platelet-rich plasma or PRP. "Platelet-rich plasma is ...
- New treatment could see humans start to live to 150 within the next decade
A treatment that enables human beings to live to the age of 150 could be available within the next five to 10 years, one of the world’s most eminent plastic surgeons has claimed.Dr Steven Cohen, who ...
Go deeper with Google Headlines on:
Regenerative medicine techniques
[google_news title=”” keyword=”regenerative medicine techniques” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Diabetic retinopathy
- Why Hypoglycemia Can Make Diabetic Retinopathy Worse
Hypoglycemia has also been linked with a condition known as diabetic retinopathy, a condition characterized by vision impairment, which can worsen. Here's why.
- Proliferative Diabetic Retinopathy Market Share by 2031
The "Proliferative Diabetic Retinopathy Market" study describes how the technology industry is evolving and how major ...
- The Diabetic Retinopathy Cascade: How Preclinical Disease Initiates Retinal Damage
With advances in imaging techniques and basic science, clinicians can detect and take action against diabetic eye disease earlier than previously considered.
- Diabetic Retinopathy (DR) Analysis Software Market Premium Research Report Forecast 2023 To 2029
Pages with Synopsis] COVID-19 Impact, Despite Inflation and Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023 Top “Diabetic Retinopathy (DR) Analysis Software Market” Size ...
- A Clinical Perspective of Diabetic Retinopathy
Diabetic retinopathy (DR) remains the leading cause of vision loss and blindness in people of working age, in spite of the fact that current treatments are effective. Vision loss occurs in DR due ...
Go deeper with Google Headlines on:
Diabetic retinopathy
[google_news title=”” keyword=”diabetic retinopathy” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]